A low tumor mutation load, lack of tumor antigen and T-cell homing chemokine, and the immunosuppressive expression of programmed cell death 1 (PD-1)/PD-L1 will lead to immune tolerance (24, 25). The gene discussed is PDCD1; the disease is neoplasm.